Dr. Mohit Agarwal is a renowned pulmonologist with over 8 years of rich experience. His areas of interest are COPD, Bronchial Asthma, Tuberculosis, ILD, Sarcoidosis, sleep medicine and lung carcinoma.
-
-
-
Life Member - Indian Chest Society
-
Life Member - European Respiratory Society
-
M. K. Gautam, V. Purohit, M. Agarwal, A. Singh, R. K. Goel, "In Vivo Healing Potential of Aegle marmelos in Excision, Incision, and Dead Space Wound Models", The Scientific World Journal, vol. 2014, Article ID 740107, 9 pages, 2014.
-
Agarwala P, Haldar B, Mandal RK, Agarwal M et al. A study of detection of mycobacteria by fluorescence microscopy in imprint smear and ziehl-neelsen stain in tissue section from skin biopsy specimen. J. Evolution Med. Dent. Sci. 2019;8(06):359-363, DOI: 10.14260/jemds/2019/79.
-
Agarwal M, Patro M, Gothi D. Hoarseness of Voice with respiratory failure: A Clue to Guillain Barre Syndrome. EC Pulmonology and Respiratory Medicine. 2019;8.11:06-09.
-
Gothi D, Patro M, Agarwal M, Vaidya S. A mysterious case of an elevated dome of the right diaphragm. Breathe 2020; 16: 190334.
-
Dipti G, Mohit A, Ishani D. Three Narcoleptics with Restless Leg Syndrome. Indian J Sleep Med 2020;15(1):5–8.
-
Patro M, Gothi D, Anand S, Agarwal M. Long-term oxygen therapy prescription in India: Evaluation of compliance, factors affecting compliance, indications, and survival. Lung India 2022;39:129-38.
-
Patro M, Gothi D, Vaidya S,Ojha UC, Agarwal M et al. Obstructive Sleep Apnea with Insomnia Overlap: An Under-recognized Entity. Indian J Chest Dis Allied Sci 2022;64(3):207–211.
-
Agarwal M, Anand S, Patro M, Gothi D. Early versus non early desaturation during 6MWT in COPD patients. A follow up study. Lung India 2023;40:235-41.
-
Choudhary D,Mishra M, Agarwal M et al. To study the profile of extrapulmonary tuberculosis at tertiary health care centre. European Journal of Molecular and Clinical Medicine 2022; 9(8): 2083-2089.
-
A Anughya, Mishra M, Agarwal M et al. Comparative study to see the incidence of acute exacerbations of COPD by triple drug therapy with single and multiple inhalers in moderate to severe disease. European Journal of Molecular and Clinical Medicine 2022; 9(8): 2090-2096.